Stock & Company Details
Supernus Pharmaceuticals Inc $SUPN
Price:
N/A
N/A
N/A
$6.1B
52 Week High:
N/A
10 Day Average Volume:
N/A
10.71
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
SUPN technical indicators
Latest Supernus Pharmaceuticals Inc (SUPN) indicator readings as of 2026-11-12.
SUPN's 14-day RSI is 30.5, in neutral territory. At $29.20 it is trading 37.1% below its 200-day moving average of $46.43, and below its 50-day average of $39.85. Price sits in the middle of its Bollinger Bands ($23.01 to $48.33). ADX reads 34.8, indicating a trending market.
SUPN backtested strategy results
How 4 rule-based strategies performed on Supernus Pharmaceuticals Inc (SUPN) over recent history, last backtested 2026-11-13. Select a strategy to plot its trades on the chart above. Past performance does not predict future results.
| Strategy | Equity curve | Return | Win rate | Trades | Max drawdown |
|---|---|---|---|---|---|
| Oversold Bounce Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | +109.8% | 56% | 9 | -23.7% | |
| Momentum Crossover Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | -2.5% | 32% | 31 | -32.8% | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | +23.5% | 33% | 33 | -23.1% | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | +22.2% | 68% | 22 | -24.9% |
Overview
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
Finance Bot
Ask your questions
Start by typing a question below.
